Chapter 7 186 16. Frawley H, Shelly B, Morin M, et al. An International Continence Society (ICS) report on the terminology for pelvic floor muscle assessment. Neurourol Urodyn. Jun 2021;40(5):1217-1260. doi:10.1002/nau.24658 17. Voorham-van der Zalm PJ, Voorham J, van den Bos TWL, Ouwerkerk TJ, et al. Reliability and differentiation of pelvic floor muscle electromyography measurements in healthy volunteers using a new device: the Multiple Array Probe Leiden (MAPLe). Neurourol Urodyn. 2013 32(4):341-8. doi:10.1002/nau.22311. 18. Tantiphlachiva K, Rao P, Attaluri A, Rao SSC. Digital rectal examination is a useful tool for identifying patients with dyssynergia. Clin Gastroenterol Hepatol. 2010;8(11):955-60. doi: 10.1016/j.cgh.2010.06.031. 19. Chiarioni G, Kim SM, Vantini I, Whitehead WE. Validation of the balloon evacuation test: reproducibility and agreement with findings from anorectal manometry and electromyography. Clin Gastroenterol Hepatol. Dec 2014;12(12):2049-54. doi:10.1016/j.cgh.2014.03.013. 20. Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. 1992;(0025-7079). 21. Dworkin RH, Turk DC, Wyrwich KW, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. Feb 2008;9(2):105-21. doi:10.1016/j.jpain.2007.09.005. 22. Castor. https://www.castoredc.com 23. Samsa G, Edelman D, Rothman ML, Williams GR, Lipscomb J, Matchar D. Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics. Feb 1999;15(2):14155. doi:10.2165/00019053-199915020-00003. 24. Hays RD, Morales LS. The RAND-36 measure of health-related quality of life. Ann Med. Jul 2001;33(5):350-7. doi:10.3109/07853890109002089. 25. Bartlett L, Sloots K, Nowak M, Ho YH. Supplementary home biofeedback improves quality of life in younger patients with fecal incontinence. J Clin Gastroenterol. May-Jun 2015;49(5):419-28. doi:10.1097/MCG.0000000000000143. 26. Cadeddu F, Salis F, De Luca E, Ciangola I, Milito G. Efficacy of biofeedback plus transanal stimulation in the management of pelvic floor dyssynergia: a randomized trial. Tech Coloproctol. Jun 2015;19(6):333-8. doi:10.1007/s10151-015-1292-7. 27. Beaty JS, Shashidharan M. Anal Fissure. Clin Colon Rectal Surg. Mar 2016;29(1):30-7. doi:10.1055/s-0035-1570390. 28. Tsunoda A, Kashiwagura Y, Hirose K, Sasaki T, Kano N. Quality of life in patients with chronic anal fissure after topical treatment with diltiazem. World J Gastrointest Surg. Nov 27 2012;4(11):251-5. doi:10.4240/wjgs.v4.i11.251. 29. Bagul A, Carter P. Quality of Life in Patients Receiving Botulinum A Toxin Treatment for Symptomatic Anal Fissure. . World J Surg Surgical Res. 2019;2:1130. 30. Sutherland JA-O, Karimuddin A, Liu G, et al. Health and quality of life among a cohort of patients having lateral internal sphincterotomy for anal fissures. Colorectal Dis. 2020;22(1463-1318):1658-1666. doi: 10.1111/codi.15191. 31. Navarro-Sánchez A, Luri-Prieto P, Compañ-Rosique A, et al. Sexuality, Quality of Life, Anxiety, Depression, and Anger in Patients with Anal Fissure. A Case-Control Study. Clin Med. 2021 Sep 26;10(19):4401. doi: 10.3390/jcm10194401.
RkJQdWJsaXNoZXIy MTk4NDMw